Reversing the risk of sudden cardiac death with gene therapy
November 21, 2019 In two (2) studies published in the journal Circulation, scientists at Boston Children’s built what could be the first human tissue model of catecholaminergic polymorphic ventricular tachycardia (CPVT), a potentially lethal form of arrhythmia that’s triggered by exercise or sudden emotional stress. Using that model, they developed a gene therapy procedure that … Read more